Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers

Reviewed

From Roche Sequencing and Life ScienceJun 8 2012

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated TnT-hs assay for use on Roche's full portfolio of laboratory analyzers. Intended as an aid in the in the diagnosis of myocardial infarction, the electrochemiluminescence (ECL) immunoassay is used for the in vitro quantitative determination of TnT-hs in human serum and plasma.

Roche Diagnostics offers a full selection of cardiac tests in its portfolio: Troponin T (TnT), Troponin I (TnI), NT-proBNP, CK-MB, Myoglobin and D-Dimer. The combination of a full cardiac menu with the lowest time of analysis on the market (STAT assay of only 9 minutes), the broadest integrated menu and ECL technology allows the Roche total solution to inspire confidence in the laboratory environment.

The assay is designed for use on all Roche immunoassay systems for low-, mid- and high-volume testing environments. The FDA has a 90-day period after the 510(k) submission for substantive review of the application.

Source:

Roche Diagnostics

Posted in: Device / Technology News | Life Sciences News | Medical Condition News

Tags: Assay, Cancer, D-dimer, Diabetes, Diagnostics, Food, Immunoassay, in vitro, Laboratory, Metabolism, Myocardial Infarction, Myoglobin, Oncology, Technology, Troponin, Virology

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Roche Sequencing and Life Science. (2019, June 20). Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20120608/Roche-files-TnT-hs-assay-510(k)-submission-with-FDA-for-use-on-laboratory-analyzers.aspx.
MLA
Roche Sequencing and Life Science. "Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20120608/Roche-files-TnT-hs-assay-510(k)-submission-with-FDA-for-use-on-laboratory-analyzers.aspx>.
Chicago
Roche Sequencing and Life Science. "Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers". News-Medical. https://www.news-medical.net/news/20120608/Roche-files-TnT-hs-assay-510(k)-submission-with-FDA-for-use-on-laboratory-analyzers.aspx. (accessed April 19, 2024).
Harvard
Roche Sequencing and Life Science. 2019. Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20120608/Roche-files-TnT-hs-assay-510(k)-submission-with-FDA-for-use-on-laboratory-analyzers.aspx.